ir_record_number,repertoire_id,repertoire_name,repertoire_description,study_id,study_title,study_contact,study_type,study_type_id,study_description,inclusion_exclusion_criteria,grants,collected_by,lab_name,lab_address,submitted_by,pub_ids,keywords_study,subject_id,synthetic,species,species_id,sex,age_min,age_max,age_unit,age_unit_id,age_event,ancestry_population,ethnicity,race,strain_name,linked_subjects,link_type,study_group_description,disease_diagnosis,disease_diagnosis_id,disease_length,disease_stage,prior_therapies,immunogen,intervention,medical_history,sample_id,sample_type,tissue,tissue_id,anatomic_site,disease_state_sample,collection_time_point_relative,collection_time_point_relative_unit,collection_time_point_relative_unit_id,collection_time_point_reference,biomaterial_provider,tissue_processing,cell_subset,cell_subset_id,cell_phenotype,cell_species,cell_species_id,single_cell,cell_number,cells_per_reaction,cell_storage,cell_quality,cell_isolation,cell_processing_protocol,template_class,template_quality,template_amount,template_amount_unit,template_amount_unit_id,library_generation_method,library_generation_protocol,library_generation_kit_version,pcr_target_locus,forward_pcr_primer_target_location,reverse_pcr_primer_target_location,complete_sequences,physical_linkage,total_reads_passing_qc_filter,ir_curator_count,sequencing_platform,read_length,paired_read_length,sequencing_facility,sequencing_run_id,sequencing_run_date,sequencing_kit,file_type,filename,read_direction,paired_filename,paired_read_direction,software_versions,paired_reads_assembly,quality_thresholds,primer_match_cutoffs,collapsing_method,data_processing_protocols,germline_database,germline_set_ref,sequencing_data_id,index_filename,index_length,primary_annotation,data_processing_files,sample_processing_id,data_processing_id,analysis_provenance_id
,,,,PRJNA744851,"Minervina et al., SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells.","Paul Thomas, paul.thomas@stjude.org",Study,NCIT:C63536,"Major histocompatibility complex multimers were utilized with single-cell RNA sequencing to profile SARS-CoV-2-responsive T cells ex vivo from humans with one, two or three antigen exposures, including vaccination, primary infection and breakthrough infection. ","A cohort of 55 individuals was selected, 16 of whom had never tested positive for SARS-CoV-2 (N1–N16), and 39 of whom were diagnosed as positive for SARS-CoV-2 with a PCR test and recovered from mild disease (R1–R30, breakthrough B1–B9) during the study period. All individuals in this study received two doses of the Pfizer-BioNTech BNT162b2 mRNA vaccine.","This work was funded by American Lebanese Syrian Associated Charities (ALSAC) at St. Jude, the Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP; contract no. 75N93019C00052), the St. Jude Center of Excellence for Influenza Research and Surveillance (HHSN272201400006C; 3U01AI144616-02S1, and R01AI136514).","Paul Thomas, paul.thomas@stjude.org","Thomas Lab, Department of Immunology, St. Jude Children’s Research Hospital","Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA","Anastasia Minervina, Anastasia.Minervina@STJUDE.ORG",DOI:10.1038/s41590-022-01184-4,contains_schema_cell,R23,FALSE,Homo sapiens,NCBITAXON:9606,female,45,45,year,UO:0000036,Study enrollment,,Non-Hispanic,"White, Caucasian",,,,inf_vax1,,,,COVID_convalescent,,Pfizer-BioNTech BNT162b2 mRNA vaccine,,,R23_inf_vax1_cell,peripheral venous puncture,venous blood,UBERON:0013756,,,96,day,UO:0000033,post COVID-19 diagnosis,"SJTRC Study Team, St. Jude Children's Research Hospital",Blood samples were collected in 8-ml CPT tubes and separated within 24 h of collection into cellular and plasma components then aliquoted and frozen.,"CD8-positive, alpha-beta memory T cell",CL:0000909,CD3+ CD8+ dextramer+,Homo sapiens,NCBITAXON:9606,TRUE,,1,TRUE,Live cells per Ghost Dye Violet 510 Viability Dye,,"Cells were stained with 5 µl Fc-block (Human TruStain FcX, BioLegend, 422302) and a cocktail of dextramers for 15 min on ice. After this, a cocktail of fluorescently labeled surface antibodies (2 µl of each: Ghost Dye Violet 510 Viability Dye, Tonbo Biosciences 13-0870-T100; anti-human CD3 FITC-conjugated (BioLegend, 300406, clone UCHT1), anti-human CD8+ BV711-conjugated (BioLegend, 344734, clone SK1)) and TotalSeq-C antibodies (1 µl anti-human CCR7 (BioLegend, 353251), 1 µl anti human CD45RA (BioLegend, 304163)) and 2 µl of TotalSeq-C anti-human hashtag antibodies 1–10 (BioLegend, 394661, 394663, 394665, 394667, 394669, 394671, 394673, 394675, 394677 and 394679) were added. Samples were incubated for 30 min on ice. Single, Live, CD3-positive, CD8-positive, dextramer-positive cells were sorted into RPMI (Gibco) containing 10% FBS and 1% penicillin–streptomycin using a Sony SY3200 cell sorter.",RNA,,,,,RT(oligo-dT)+TS(UMI)+PCR,"Chromium Next GEM Single-Cell 5′ kits v.2 (10x Genomics: 1000265, 1000286, 1000250, 1000215, 1000252 1000190 and 1000080) were used to generate GEX, VDJ and Cite-seq libraries according to the manufacturer’s protocol.",,,,,partial,none,,468,Illumina NovaSeq,26,90,,,,,fastq,,,,,Cell Ranger (v.6.0.0) count pipeline,,,,,Raw data were processed with Cell Ranger v.6.0.0 (10x Genomics). Three batches were subsequently combined using the aggregate function with default parameters. ,,,,,,TRUE,"R23_inf_vax1-t-cells.json, R23_inf_vax1-t_gex.json",,,
,,,,PRJNA744851,"Minervina et al., SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells.","Paul Thomas, paul.thomas@stjude.org",Study,NCIT:C63536,"Major histocompatibility complex multimers were utilized with single-cell RNA sequencing to profile SARS-CoV-2-responsive T cells ex vivo from humans with one, two or three antigen exposures, including vaccination, primary infection and breakthrough infection. ","A cohort of 55 individuals was selected, 16 of whom had never tested positive for SARS-CoV-2 (N1–N16), and 39 of whom were diagnosed as positive for SARS-CoV-2 with a PCR test and recovered from mild disease (R1–R30, breakthrough B1–B9) during the study period. All individuals in this study received two doses of the Pfizer-BioNTech BNT162b2 mRNA vaccine.","This work was funded by American Lebanese Syrian Associated Charities (ALSAC) at St. Jude, the Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP; contract no. 75N93019C00052), the St. Jude Center of Excellence for Influenza Research and Surveillance (HHSN272201400006C; 3U01AI144616-02S1, and R01AI136514).","Paul Thomas, paul.thomas@stjude.org","Thomas Lab, Department of Immunology, St. Jude Children’s Research Hospital","Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA","Anastasia Minervina, Anastasia.Minervina@STJUDE.ORG",DOI:10.1038/s41590-022-01184-4,contains_schema_cell,R23,FALSE,Homo sapiens,NCBITAXON:9606,female,45,45,year,UO:0000036,Study enrollment,,Non-Hispanic,"White, Caucasian",,,,inf_vax2,,,,,,Pfizer-BioNTech BNT162b2 mRNA vaccine,,,R23_inf_vax2_cell,peripheral venous puncture,venous blood,UBERON:0013756,,,37,day,UO:0000033,post second vaccination,"SJTRC Study Team, St. Jude Children's Research Hospital",Blood samples were collected in 8-ml CPT tubes and separated within 24 h of collection into cellular and plasma components then aliquoted and frozen.,"CD8-positive, alpha-beta memory T cell",CL:0000909,CD3+ CD8+ dextramer+,Homo sapiens,NCBITAXON:9606,TRUE,,1,TRUE,Live cells per Ghost Dye Violet 510 Viability Dye,,"Cells were stained with 5 µl Fc-block (Human TruStain FcX, BioLegend, 422302) and a cocktail of dextramers for 15 min on ice. After this, a cocktail of fluorescently labeled surface antibodies (2 µl of each: Ghost Dye Violet 510 Viability Dye, Tonbo Biosciences 13-0870-T100; anti-human CD3 FITC-conjugated (BioLegend, 300406, clone UCHT1), anti-human CD8+ BV711-conjugated (BioLegend, 344734, clone SK1)) and TotalSeq-C antibodies (1 µl anti-human CCR7 (BioLegend, 353251), 1 µl anti human CD45RA (BioLegend, 304163)) and 2 µl of TotalSeq-C anti-human hashtag antibodies 1–10 (BioLegend, 394661, 394663, 394665, 394667, 394669, 394671, 394673, 394675, 394677 and 394679) were added. Samples were incubated for 30 min on ice. Single, Live, CD3-positive, CD8-positive, dextramer-positive cells were sorted into RPMI (Gibco) containing 10% FBS and 1% penicillin–streptomycin using a Sony SY3200 cell sorter.",RNA,,,,,RT(oligo-dT)+TS(UMI)+PCR,"Chromium Next GEM Single-Cell 5′ kits v.2 (10x Genomics: 1000265, 1000286, 1000250, 1000215, 1000252 1000190 and 1000080) were used to generate GEX, VDJ and Cite-seq libraries according to the manufacturer’s protocol.",,,,,partial,none,,594,Illumina NovaSeq,26,90,,,,,fastq,,,,,Cell Ranger (v.6.0.0) count pipeline,,,,,Raw data were processed with Cell Ranger v.6.0.0 (10x Genomics). Three batches were subsequently combined using the aggregate function with default parameters. ,,,,,,TRUE,"R23_inf_vax2-t-cells.json, R23_inf_vax2-t_gex.json,R23_reactivity.json",,,
